Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
40,575,589
-
Share change
-
-497,807
-
Total reported value
-
$322,487,913
-
Price per share
-
$7.95
-
Number of holders
-
75
-
Value change
-
-$2,794,370
-
Number of buys
-
31
-
Number of sells
-
33
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q3 2021
As of 30 Sep 2021,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,575,589 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, PICTET ASSET MANAGEMENT SA, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Aisling Capital Management LP, and Rock Springs Capital Management LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.